Protalix BioTherapeutics (PLX) EBT Margin (2010 - 2026)
Protalix BioTherapeutics (PLX) posted EBT Margin of 24.43% for Q2 2026, up 20.21 percentage points from 4.22% a year earlier but down 38.21 percentage points from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EBT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Protalix BioTherapeutics was 29.10%, up 16.05 percentage points year-over-year; for FY2025, it was -10.63%, down 18.41 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of -0.26 percentage points (FY2020 to FY2025).
- In prior years, Protalix BioTherapeutics' EBT Margin was 7.78% in FY2024 (-5.30 pp), 13.08% in FY2023 (+43.30 pp), -30.22% in FY2022 (+41.70 pp) and -71.92% in FY2021 (-61.55 pp).
- Quarterly EBT Margin has run from a low of -126.28% in Q1 2024 to a high of 62.64% in Q1 2026 over five years.
- On a year-over-year basis, EBT Margin increased in six of the last eight quarters, with an average year-over-year change of +33.54 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q2 2023, with a gain of 116.95 percentage points; the weakest was Q1 2024, with a drop of 95.66 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was 62.64% (Q1 2026), -52.36% (Q4 2025) and 12.54% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn | 24.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.43% |
| Mar 31, 2026 | 62.64% |
| Dec 31, 2025 | -52.36% |
| Sep 30, 2025 | 12.54% |
| Jun 30, 2025 | 4.22% |
| Mar 31, 2025 | -36.90% |
| Dec 31, 2024 | 40.16% |
| Sep 30, 2024 | 21.40% |
| Jun 30, 2024 | -16.86% |
| Mar 31, 2024 | -126.28% |
| Dec 31, 2023 | -61.28% |
| Sep 30, 2023 | -16.62% |
| Jun 30, 2023 | 56.01% |
| Mar 31, 2023 | -30.62% |
| Dec 31, 2022 | -37.25% |
| Sep 30, 2022 | -25.15% |
| Jun 30, 2022 | -60.94% |
| Mar 31, 2022 | -14.21% |
| Dec 31, 2021 | -66.74% |
| Sep 30, 2021 | -15.64% |
API Access
Protalix BioTherapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();